by Anum Ahmed | Feb 19, 2022 | Central, Drugs and medicine, OPS | 0 comments Health Ministry eases norms for manufacture and stocking of new drugs (under Phase III clinical trials) for treating Covid-19 and related diseases You need to be logged in to view this content. Please Log In. Not a Member? Join Us Share this: 0 shares Share Tweet Pin LinkedIn Related Posts:Health Ministry writes to States and Union…Public comments invited on the draft amendments to…CDSCO proposes the Draft New Drugs and Clinical…Ministry of Health releases revised National List of… centralDrugs and MedicinesOperations Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Math Captcha 90 − = 87